Surjendu Maity
Articles
-
1 month ago |
biorxiv.org | Saurabh Sharma |David Lee |Surjendu Maity |Prabhjeet Singh
AbstractGlioblastoma Multiforme (GBM) represents a significant clinical challenge amongst central nervous system (CNS) tumors, with a dismal mean survival rate of less than 8 months, a statistic that has remained largely unchanged for decades (National Brain Society, 2022).
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →